Viewing Study NCT02202161


Ignite Creation Date: 2025-12-24 @ 11:52 AM
Ignite Modification Date: 2026-02-05 @ 6:22 AM
Study NCT ID: NCT02202161
Status: COMPLETED
Last Update Posted: 2017-11-06
First Post: 2014-07-24
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 Administered With Metformin to Type 2 Diabetes Patients
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes Mellitus, Type 2 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None pharmacokinetic View
None intestinal bile acid transporter inhibitor View
None metformin View
None sitagliptin View
None GSK2330672 View
None pharmacodynamic View